Skip to content

Clinical trials

Leukemia, Myeloid, Chronic-Phase trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Country / region: Spain Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20101
20121
20141
20151
20203
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting5
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb5
Ascentage Pharma Group Inc.1
Children's Oncology Group1
Enliven Therapeutics1
European Organisation for Research and Treatment of Cancer - EORTC1
Fundacion CRIS de Investigación para Vencer el Cáncer1
Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
III. Medizinische Klinik Mannheim1
Incyte Biosciences International Sàrl1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive10
Blast Crisis3
Leukemia3
Leukemia, Myeloid, Accelerated Phase3
Leukemia, Myeloid, Acute2
Neoplasms2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Bone Marrow Diseases1
Breast Neoplasms1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.